Canada markets closed

Myomo, Inc. (MYO)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
7.65-0.31 (-3.89%)
At close: 04:00PM EST
7.65 0.00 (0.00%)
After hours: 04:10PM EST

Myomo, Inc.

137 Portland Street
4th Floor
Boston, MA 02114
United States
617 996 9058

IndustryMedical Devices
Full Time Employees62

Key Executives

NameTitlePayExercisedYear Born
Mr. Paul R. GudonisChairman, Pres & CEO439.71kN/A1955
Mr. David A. HenryChief Financial Officer375.35kN/A1961
Mr. Micah J. MitchellChief Commercial Officer320.61kN/A1976
Mr. Clifford J. ConneightonChief Marketing OfficerN/AN/A1950
Dr. Harry Kovelman M.D.Chief Medical OfficerN/AN/A1959
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to restore function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Corporate Governance

Myomo, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.